Epstein Secrets

nd when there are rumors and disinformation and misinformation we need a trusted source in government to say, 'Yes, this is true' or'No, it isn't." Senate Intelligence Committee Vice Chairman Sen. Mark Warner (D-VA) said, "Chris Krebs has done a great job protecting our elections. ... There is no possible justification to r

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

nd when there are rumors and disinformation and misinformation we need a trusted source in government to say, 'Yes, this is true' or'No, it isn't." Senate Intelligence Committee Vice Chairman Sen. Mark Warner (D-VA) said, "Chris Krebs has done a great job protecting our elections. ... There is no possible justification to r

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

nd when there are rumors and disinformation and misinformation we need a trusted source in government to say, 'Yes, this is true' or'No, it isn't." Senate Intelligence Committee Vice Chairman Sen. Mark Warner (D-VA) said, "Chris Krebs has done a great job protecting our elections. ... There is no possible justification to r

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying